Effect of anaesthetic technique and other perioperative factors on cancer recurrence

British Journal of Anaesthesia

Volumn 105, Issue 2, 2010, Pages 106-115

  Snyder, G L ^a   Greenberg, S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

anaesthesia; cancer; outcome; perioperative

Indexed keywords

ANGIOSTATIN; CELECOXIB; DIAZEPAM; DOCOSAHEXAENOIC ACID; ENDOSTATIN; EPIDERMAL GROWTH FACTOR; ETODOLAC; FENTANYL; GAMMA INTERFERON; HALOTHANE; ICOSAPENTAENOIC ACID; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; ISOFLURANE; KETAMINE; LIDOCAINE; MORPHINE; NITROUS OXIDE; PROPOFOL; PROSTAGLANDIN E2; PURINE; ROPIVACAINE; THIOPENTAL; TRAMADOL; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VOLATILE AGENT;

ANESTHESIOLOGICAL TECHNIQUES; ANGIOGENESIS; ANTIBODY PRODUCTION; ANXIETY; APOPTOSIS; AUTOPSY; BLADDER TUMOR; BLOOD TRANSFUSION; BONE MARROW; BREAST CANCER; CANCER CELL; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CAPILLARY; CELL ACTIVITY; CELL ADHESION; CELL COUNT; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL TRIAL; COLON RESECTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DISEASE FREE SURVIVAL; DNA SYNTHESIS; DRUG CHOICE; DRUG EFFECT; EPIDURAL ANESTHESIA; GENERAL ANESTHESIA; HELPER CELL; HOST RESISTANCE; HUMAN; HYPOTHERMIA; HYSTERECTOMY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TUMOR; LAPAROSCOPIC SURGERY; LAPAROTOMY; LARGE GRANULAR LYMPHOCYTE; LUNG TUMOR; LYMPHATIC SYSTEM; MACROPHAGE; MELANOMA; MENTAL STRESS; METASTASIS; MICROMETASTASIS; MIGRATION INHIBITION; MINIMAL RESIDUAL DISEASE; MONONUCLEAR CELL; MYELOMA; NATURAL KILLER CELL; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL; NONHUMAN; NUTRIENT SUPPLY; OUTCOME ASSESSMENT; PAIN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSTATECTOMY; PROTEIN BLOOD LEVEL; PURINE SYNTHESIS; REGIONAL ANESTHESIA; RETROSPECTIVE STUDY; REVIEW; SARCOMA; SKIN TUMOR; SPONTANEOUS MUTATION; UTERUS CARCINOMA;

EID: 77954843916     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeq164     Document Type: Review

References (82)

1. Sessler DI. Long-term consequences of anesthetic management. Anesthesiology 2009; 111: 1-4
2. Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 2006; 105: 660-664
3. Society AC. Cancer Facts and Figures 2007. Atlanta: American Cancer Society, 2007
4. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249
5. Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol 2003; 10: 972-992
6. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev 2003; 3: 453-458
7. O'Riain SC, Buggy DJ, Kerin MJ, Watson RW, Moriarty DC. Inhibition of the stress response to breast cancer surgery by regional anesthesia and analgesia does not affect vascular endothelial growth factor and prostaglandin E2. Anesth Analg 2005; 100: 244-249
8. Langley RR, Fidler IJ. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 2007; 28: 297-321
9. Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 2008; 109: 180-187
10. Brittenden J, Heys SD, Ross J, Eremin O. Natural killer cells and cancer. Cancer 1996; 77: 1226-1243
11. Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 1999; 80: 880-888
12. Andersen BL, Farrar WB, Golden-Kreutz D et al. Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst 1998; 90: 30-36
13. Uchida A, Kariya Y, Okamoto N, Sugie K, Fujimoto T, Yagita M. Prediction of postoperative clinical course by autologous tumor-killing activity in lung cancer patients. J Natl Cancer Inst 1990; 82: 1697-1701
14. Penn I. The effect of immunosuppression on pre-existing cancers. Transplantation 1993; 55: 742-747
15. Garcia-Lora A, Algarra I, Gaforio JJ, Ruiz-Cabello F, Garrido F. Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants. Int J Cancer 2001; 91: 109-119
16. Mansi JL, Gogas H, Bliss JM, Gazet JC, Berger U, Coombes RC. Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study. Lancet 1999; 354: 197-202
17. Coffey JC, Wang JH, Smith MJ, Bouchier-Hayes D, Cotter TG, Redmond HP. Excisional surgery for cancer cure: therapy at a cost. Lancet Oncol 2003; 4: 760-768
18. Yamaguchi K, Takagi Y, Aoki S, Futamura M, Saji S. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 2000; 232: 58-65
19. Buggy DJ, Smith G. Epidural anaesthesia and analgesia: better outcome after major surgery? Growing evidence suggests so. Br Med J 1999; 319: 530-531
20. Vittimberga FJ Jr, Foley DP, Meyers WC, Callery MP. Laparoscopic surgery and the systemic immune response. Ann Surg 1998; 227: 326-334
21. Lacy AM, Garcia-Valdecasas JC, Delgado S et al. Laparoscopyassisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 2002; 359: 2224-2229
22. Tsuchiya Y, Sawada S, Yoshioka I et al. Increased surgical stress promotes tumor metastasis. Surgery 2003; 133: 547-555
23. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70
24. Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg 2003; 97: 1331-1339
25. Katzav S, Shapiro J, Segal S, Feldman M. General anesthesia during excision of a mouse tumor accelerates postsurgical growth of metastases by suppression of natural killer cell activity. Israel J Med Sci 1986; 22: 339-345
26. Siddiqui RA, Zerouga M, Wu M et al. Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells. Breast Cancer Res 2005; 7: R645-54
27. Markovic SN, Knight PR, Murasko DM. Inhibition of interferon stimulation of natural killer cell activity in mice anesthetized with halothane or isoflurane. Anesthesiology 1993; 78: 700-706
28. Mitsuhata H, Shimizu R, Yokoyama MM. Suppressive effects of volatile anesthetics on cytokine release in human peripheral blood mononuclear cells. Int J Immunopharmacol 1995; 17: 529-534
29. Schlagenhauff B, Ellwanger U, Breuninger H, Stroebel W, Rassner G, Garbe C. Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Res 2000; 10: 165-169
30. Brand JM, Kirchner H, Poppe C, Schmucker P. The effects of general anesthesia on human peripheral immune cell distribution and cytokine production. Clin Immunol Immunopathol 1997; 83: 190-194
31. Sessler DI. Does regional analgesia reduce the risk of cancer recurrence? A hypothesis. Eur J Cancer Prev 2008; 17: 269-272
32. Weimann J. Toxicity of nitrous oxide. Best Pract Res 2003; 17: 47-61
33. Shapiro J, Jersky J, Katzav S, Feldman M, Segal S. Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors. J Clin Invest 1981; 68: 678-685
34. Fleischmann E, Lenhardt R, Kurz A et al. Nitrous oxide and risk of surgical wound infection: a randomised trial. Lancet 2005; 366: 1101-1107
35. Fleischmann E, Schlemitz K, Dalton JE et al. Nitrous Oxide may not increase the risk of cancer recurrence after colorectal surgery: a follow-up of a randomized controlled trial. BMC Anesthesiol 2009; 9: 9
36. Sakaguchi M, Kuroda Y, Hirose M. The antiproliferative effect of lidocaine on human tongue cancer cells with inhibition of the activity of epidermal growth factor receptor. Anesth Analg 2006; 102: 1103-1107
37. Mammoto T, Higashiyama S, Mukai M et al. Infiltration anesthetic lidocaine inhibits cancer cell invasion by modulating ectodomain shedding of heparin-binding epidermal growth factor-like growth factor (HB-EGF). J Cell Physiol 2002; 192: 351-358
38. Martinsson T. Ropivacaine inhibits serum-induced proliferation of colon adenocarcinoma cells in vitro. J Pharmacol Exp Ther 1999; 288: 660-664
39. Vallejo R, de Leon-Casasola O, Benyamin R. Opioid therapy and immunosuppression: a review. Am J Ther 2004; 11: 354-365
40. Beilin B, Martin FC, Shavit Y, Gale RP, Liebeskind JC. Suppression of natural killer cell activity by high-dose narcotic anesthesia in rats. Brain Behav Immun 1989; 3: 129-137
41. Gupta K, Kshirsagar S, Chang L et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 2002; 62: 4491-4498
42. Farooqui M, Li Y, Rogers T et al. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer 2007; 97: 1523-1531
43. Beilin B, Shavit Y, Hart J et al. Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg 1996; 82: 492-497
44. Yeager MP, Colacchio TA, Yu CT et al. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology 1995; 83: 500-508
45. Page GG, McDonald JS, Ben-Eliyahu S. Pre-operative versus postoperative administration of morphine: impact on the neuroendocrine, behavioural, and metastatic-enhancing effects of surgery. Br J Anaesth 1998; 81: 216-223
46. Sasamura T, Nakamura S, Iida Y et al. Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation. Eur J Pharmacol 2002; 441: 185-191
47. Gaspani L, Bianchi M, Limiroli E, Panerai AE, Sacerdote P. The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats. J Neuroimmunol 2002; 129: 18-24
48. Sacerdote P, Bianchi M, Gaspani L et al. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg 2000; 90: 1411-1414
49. Wojtowicz-Praga S. Reversal of tumor-induced immunosuppression by TGF-beta inhibitors. Invest New Drugs 2003; 21: 21-32
50. Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res 2002; 62: 625-631
51. Benish MBI, Goldfarb Y, Levi B, Avraham R, Raz A, Ben-Eliyahu S. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol 2009; 15: 11
52. Harris RE, Beebe-Donk J, Alshafie GA. Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer 2006; 6: 27
53. Dirix LY, Ignacio J, Nag S et al. Treatment of advanced hormonesensitive breast cancer in postmenopausal women with exemestane alone or in combination with celecoxib. J Clin Oncol 2008; 26: 1253-1259
54. Tsui BC, Rashiq S, Schopflocher D et al. Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Can J Anaesth 2010; 57: 107-112
55. Sessler DIB-ES, Mascha E, ParatM, Buggy DJ. Can regional analgesia reduce the risk of recurrence after breast cancer? Methodology of a multicenter randomized trial. Contemp Clin Trials 2008; 29: 9
56. Wada H, Seki S, Takahashi T et al. Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance. Anesthesiology 2007; 106: 499-506
57. Bar-Yosef S, Melamed R, Page GG, Shakhar G, Shakhar K, Ben- Eliyahu S. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 2001; 94: 1066-1073
58. Deegan CA, Murray D, Doran P, Ecimovic P, Moriarty DC, Buggy DJ. Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. Br J Anaesth 2009; 103: 685-690
59. Colozza M, Azambuja E, Cardoso F, Sotiriou C, Larsimont D, Piccart MJ. Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? Ann Oncol 2005; 16: 1723-1739
60. Moller JF, Nikolajsen L, Rodt SA, Ronning H, Carlsson PS. Thoracic paravertebral block for breast cancer surgery: a randomized double-blind study. Anesth Analg 2007; 105: 1848-1851
61. Shavit Y, Martin FC, Yirmiya R et al. Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity. Brain Behav Immun 1987; 1: 318-328
62. Sacerdote P, Manfredi B, Bianchi M, Panerai AE. Intermittent but not continuous inescapable footshock stress affects immune responses and immunocyte beta-endorphin concentrations in the rat. Brain Behav Immun 1994; 8: 251-260
63. Page GG, Blakely WP, Ben-Eliyahu S. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain 2001; 90: 191-199
64. Page GG. Acute pain and immune impairment. Pain Clin Updates 2005; 13: 1-4
65. Weber RS, Jabbour N, Martin RC II. Anemia and transfusions in patients undergoing surgery for cancer. Ann Surg Oncol 2008; 15: 34-45
66. Blajchman MA. Transfusion-associated immunomodulation and universal white cell reduction: are we putting the cart before the horse? Transfusion 1999; 39: 665-670
67. Kaplan J, Sarnaik S, Gitlin J, Lusher J. Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 1984; 64: 308-310
68. Brunson ME, Alexander JW. Mechanisms of transfusion-induced immunosuppression. Transfusion 1990; 30: 651-658
69. Blajchman MA, Bardossy L, Carmen R, Sastry A, Singal DP. Allogeneic blood transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood 1993; 81: 1880-1882
70. Ydy LR, Slhessarenko N, de Aguilar-Nascimento JE. Effect of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response after colorectal cancer resection. World J Surg 2007; 31: 2044-2051
71. Chen G, Zhang FJ, Gong M, Yan M. Effect of perioperative autologous versus allogeneic blood transfusion on the immune system in gastric cancer patients. J Zhejiang Univ Sci 2007; 8: 560-565
72. Vamvakas EC, Carven JH. Allogeneic blood transfusion, hospital charges, and length of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection. Arch Path Lab Med 1998; 122: 145-151
73. Ling FC, Hoelscher AH, Vallbohmer D et al. Leukocyte depletion in allogeneic blood transfusion does not change the negative influence on survival following transthoracic resection for esophageal cancer. J Gastrointest Surg 2009; 13: 581-586
74. Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993; 328: 1372-1376 (Pubitemid 23131389)
75. Heiss MM, Mempel W, Delanoff C et al. Blood transfusionmodulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994; 12: 1859-1867
76. Houbiers JG, Brand A, van de Watering LM et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994; 344: 573-578
77. Colacchio TA, Yeager MP, Hildebrandt LW. Perioperative immunomodulation in cancer surgery. Am J Surg 1994; 167: 174-179
78. Ben-Eliyahu S. The price of anticancer intervention. Does surgery promote metastasis? Lancet Oncol 2002; 3: 578-579
79. Ben-Eliyahu S, Shakhar G, Rosenne E, Levinson Y, Beilin B. Hypothermia in barbiturate-anesthetized rats suppresses natural killer cell activity and compromises resistance to tumor metastasis: a role for adrenergic mechanisms. Anesthesiology 1999; 91: 732-740
80. Beilin B, Shavit Y, Razumovsky J, Wolloch Y, Zeidel A, Bessler H. Effects of mild perioperative hypothermia on cellular immune responses. Anesthesiology 1998; 89: 1133-1140
81. Stefanski V, Ben-Eliyahu S. Social confrontation and tumor metastasis in rats: defeat and beta-adrenergic mechanisms. Physiol Behav 1996; 60: 277-282
82. Fried IA. The influence of the anaesthetic on survival rates of breast cancer patients after surgery. Int J Cancer 1977; 20: 213-218